BACR Annual Meeting 2022

Tumour plasticity and heterogeneity during cancer progression

Program          Registration          Abstract          Venue           Sponsors


THE ONLINE ABSTRACT BOOK IS AVAILABLE HERE.

9:00 Registration, poster mounting & coffee
9:30 – 12:15 MORNING SESSION
Chairs: Prof. dr. Geert Berx & Prof. dr. Tom Boterberg
9:30 Prof. dr. Geert Berx
Introduction
9:45
Prof. Dr. Jean-Christophe Marine, Laboratory for Molecular Cancer Biology VIB-KU Leuven, Belgium
Dissecting the functional intratumoral heterogeneity in melanoma
10:15
Prof Dr. ir. Damya Laoui, Bioengineering Sciences Department, Cellular and Molecular Immunology, VUB, Belgium
Dendritic cells in the tumor microenvironment: which subpopulation to use for cancer therapy?
10:45 Coffee break & Poster viewing
11:15 Young investigators: oral presentations of 4 selected abstracts

Immune and microbiota interplay during murine colorectal cancer development and therapy

Marie Thorp (UGent)

Microenvironment-mediated lipid metabolism reprogramming upon anti-EGFR therapy resistance in squamous cell carcinoma of the head and neck

Valentin Van Den Bossche (UCLouvain)

A mouse model to study melanoma dermal invasion

Nina Van Raemdonck (KULeuven)

Dynamic quantification of treatment resistant and invasive subclones at single-organoid level reveals the response heterogeneity in pancreatic cancer

Maxim Le Compte (UAntwerpen)

12:15 BACR: general assembly (members only)
12:30 – 14:00 LUNCH AND POSTER SESSION
14:00 – 16:30 AFTERNOON SESSION
Chair: Prof. dr. Akeila Bellahcène
14:00 Young investigators: oral presentations of 4 selected abstract

Distinct transcriptional programs in ascitic and solid cancer cells induce different responses to chemotherapy in high-grade serous ovarian cancer

Jordy De Coninck (UGent)

 Immunosuppressive effect of methylglyoxal stress in breast cancer

Victoria Mohring (ULiège)

S-adenosylmethionine Biosynthesis is a Targetable Metabolic Vulnerability in Multiple Myeloma

Yanmeng Wang (VUBrussel)

mTORC2 activation drives the reprogramming of lipid metabolism to support lung cancer progression

Arnaud Blomme (ULiège)

15:00 Coffee break
15:30
Prof. dr. Jacco van Rheenen, Netherlands Cancer Institute, Amsterdam, The Netherlands.

Filming the fate of cells that carry mutations in oncogenic driver genes

16:00 Prof. dr. Katleen De Preter, CRIG, Ghent University

Neuroblastoma: a heterogeneous tumour of childhood
16:30 Awards ceremony for best oral and poster presentations
Concluding remarks
17:00 End of conference